Last reviewed · How we verify
Bacterial keratitis
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Cortisporin · Pfizer
- Garamycin · Merck & Co.
- Cortifoam · Pfizer
- Cortone
- Decadron · Generic (originally Merck)
- Gentamicin · Merck & Co.
- Cortisporin · Pfizer
- Cortef · Generic (originally Merck/Upjohn)
- Cortisporin · Pfizer
- Gramoderm · Pfizer
- Cortisol · University of Zurich
- Prelone · Generic (originally Schering)
- prednisolon · Hannover Medical School
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Bacterial keratitis patent landscape — cliff calendar, originator estates, attackable patents
- Bacterial keratitis treatment landscape brief
- Bacterial keratitis treatment updates RSS
Frequently asked questions about Bacterial keratitis
What drugs treat Bacterial keratitis?
Tracked treatments include Ramycin, Cortisporin, Garamycin, Cortifoam, Cortone, Decadron, Gentamicin, Cortef.
What is the treatment for Bacterial keratitis?
Standard treatment for Bacterial keratitis includes Ramycin, Cortisporin, Garamycin, Cortifoam, Cortone. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Bacterial keratitis patent cliff · Bacterial keratitis CI report
- Treatment: Ramycin
- Treatment: Cortisporin · Pfizer
- Treatment: Garamycin · Merck & Co.
- Treatment: Cortifoam · Pfizer
- Treatment: Cortone
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing